Exagen will expand its medicare coverage with MediNcrease to increase the accessibility of specialized diagnostic testing solutions and offer excellent medical care.
Fremont, CA: It is a noted fact that medical emergencies can arise at any time. Hence, it is necessary to get adequate health insurance cover, which will assist people financially manage medical situations better. Also, nowadays, medical claims need to cover more and more areas, including autoimmune diseases, as there are people who may have medical claims and can still not cover their expenses because of the non-inclusivity of various diseases in their healthcare plans. Exagen, a leading provider of autoimmune testing solutions, has incorporated Exagen Inc. into the national provider network of MediNcrease Health Plans, LLC, thereby enhancing care for their nearly 7.5 million commercial lives. AVISE® assays, including AVISE® Lupus and AVISE® CTD, will be accessible through MediNcrease's client network of regional and national health plans, insurance companies, employers, municipalities, third-party administrators, unions, and other entities involved in the management of medical claims.
"Our partnership with MediNcrease is an exciting step forward. This partnership will provide the client base, members, and providers of MediNcrease Health Plans, access to a timely and accurate differential diagnosis for complex autoimmune diseases, including Systemic Lupus Erythematosus (SLE)," comments Ron Rocca, Exagens President, and CEO. "SLE is a complex autoimmune disease, and the earlier a diagnosis is reached the better chance a patient has to prevent irreversible organ damage."
"We are thrilled to welcome Exagen to the MediNcrease provider network," states Linda Plaster, Managing Partner of MediNcrease Health Plans. "This exciting relationship affirms continued commitment to our specialty lab network expansion and increasing the accessibility of specialized diagnostic testing solutions."